Enterprise MRI AI is no longer just about faster scans. For healthcare executives, the bigger opportunity is improving performance across existing MRI infrastructure while controlling costs and expanding patient access.
When MRI demand exceeds available capacity, purchasing another scanner may seem like the logical next step. But for large imaging networks, the decision is rarely that straightforward.
Capital budgets are constrained. MRI fleets include equipment from multiple manufacturers and generations. Radiologists expect consistent diagnostic image quality, while IT teams must manage integration, security, and performance across numerous facilities.
The challenge isn’t simply finding AI technology that works on one scanner. It’s finding a solution that delivers measurable clinical, operational, and financial value across an entire imaging organization.
Three imaging providers—SimonMed Imaging, MedStar Health, and Invision Sally Jobe—have taken different approaches to that challenge using AIRS Medical’s SwiftMR®, an AI-powered MRI reconstruction solution.
Their experiences illustrate three important enterprise priorities: scalability, clinical confidence, and capital efficiency.
SimonMed Imaging: Standardizing MRI Performance Across a Diverse Fleet
For a large outpatient imaging network, scanner diversity creates a fundamental operational challenge.
As organizations expand, often through acquisitions, they inherit MRI systems from different manufacturers, spanning multiple field strengths, equipment generations, and levels of technology.
SimonMed Imaging faced precisely this challenge across its national network.
The organization needed more than faster MRI examinations. It wanted a common reconstruction foundation that could support more consistent imaging performance across its existing infrastructure without requiring fleet-wide hardware replacement.
After evaluating leading MRI AI solutions, SimonMed selected SwiftMR and moved rapidly from its technology decision to enterprise deployment.
The Results
- 200+ MRI scanners deployed in 10 days
- Implementation across multiple manufacturers, field strengths, and scanner generations
- No new scanner hardware required
Rather than addressing MRI performance through separate equipment upgrades, SimonMed established a common AI reconstruction platform across its heterogeneous fleet.
The significance extends beyond deployment speed.
As imaging organizations move toward quantitative analysis and longitudinal assessment, consistency across scanners becomes increasingly important. Variations in equipment and acquisition can complicate comparisons between examinations performed at different locations or over time.
A more consistent reconstruction foundation can help address part of that challenge, although reproducible quantitative measurements still require separate clinical and technical validation.
The enterprise takeaway: MRI AI should be evaluated for its ability to support the entire installed scanner base—not just the newest equipment or a successful single-site pilot.
Read the SimonMed enterprise case study
MedStar Health: Building Clinical Confidence Before Enterprise Deployment
Even when MRI AI demonstrates meaningful scan-time reductions, that alone may not be enough to secure enterprise adoption.
Radiologists must trust the reconstructed images. Technologists need workflows they can use consistently. IT teams require integration, security, and operational resilience.
At MedStar Health, one of the largest healthcare systems in the Maryland–Washington, D.C. region, these considerations shaped its evaluation of SwiftMR.
MedStar operates 10 hospitals and more than 90 imaging locations, serving patients across inpatient and outpatient environments.
Rather than moving directly to a broad rollout, the organization conducted a structured, 60-day radiologist-led clinical evaluation.
Radiologist champions reviewed image quality across anatomical specialties, including challenging clinical cases. The AIRS Medical team worked with clinicians to refine imaging protocols and address feedback before deployment.
The evaluation demonstrated substantial reductions in MRI acquisition time while supporting the organization’s image-quality requirements.
The Results
- 38–39% total scan-time reduction on evaluated Siemens Aera 1.5T inpatient and outpatient MRI protocols
- 60-day radiologist-led clinical evaluation
- SwiftMR subsequently deployed across 13 imaging locations
- Centrally managed deployment integrated into existing MRI and PACS workflows
The operational benefits differed by care setting.
Inpatient environments benefited from more predictable examination times amid complex schedules and interruptions. Outpatient facilities could use shorter protocols to support reduced appointment slots and greater scheduling capacity.
Equally important was the implementation approach. MedStar’s enterprise rollout brought radiology, IT, and operations together around clinical approval, infrastructure requirements, and workflow integration.
The enterprise takeaway: Successful MRI AI adoption requires clinical validation and enterprise IT readiness to be addressed together. Faster scans create value only when the solution can be trusted, integrated, and used consistently.
Read the MedStar Health enterprise case study
Invision Sally Jobe: Increasing MRI Capacity Without Purchasing Another Scanner
For imaging executives facing growing demand, the financial question is often whether additional capacity requires additional capital equipment.
Invision Sally Jobe, a Denver-area imaging network operating in partnership with Radiology Imaging Associates, faced increasing MRI volumes across several facilities.
Leadership considered three approaches: purchasing another MRI scanner, upgrading existing equipment through the original manufacturer, or improving performance through AI-powered reconstruction.
A new scanner represented an investment exceeding $1.5 million. Manufacturer upgrades also involved substantial costs.
Rather than committing to new hardware, Invision Sally Jobe implemented SwiftMR across existing Siemens and GE MRI systems.
The organization measured the impact on scan times, patient throughput, and equipment utilization.
The Results
- $1.5 million+ in estimated capital expenditure avoided by eliminating the need for an additional scanner purchase
- 29% average increase in patient throughput across three locations within the first three months
- 43% average scan-time reduction at its Southwest and Littleton facilities
- Increased capacity using existing MRI infrastructure
These results illustrate the connection between MRI performance and financial planning.
Shorter examinations created opportunities to schedule additional patients without increasing the number of scanners. For Invision Sally Jobe, this helped address growing demand while preserving capital for other organizational priorities.
Importantly, the $1.5 million figure represents an estimated equipment purchase that was avoided, rather than realized operating savings. The financial impact was also tied to the organization’s specific scanner fleet, patient demand, and scheduling environment.
The enterprise takeaway: Before committing to additional MRI equipment, imaging leaders should determine whether improvements to existing scanner performance could satisfy capacity requirements at a lower total investment.
Read the Invision Sally Jobe case study
What These Case Studies Mean for Enterprise MRI AI Investment Decisions
The three organizations achieved different outcomes because they were addressing different business priorities.
SimonMed focused on enterprise standardization across a diverse MRI fleet. MedStar Health prioritized clinical validation and operational integration. Invision Sally Jobe concentrated on expanding capacity while conserving capital.
These distinctions matter.
A successful deployment across hundreds of scanners does not, by itself, establish financial ROI. A 39% reduction in scan time does not automatically mean 39% more patients can be scheduled. And avoiding a new equipment purchase depends on whether the additional capacity created is sufficient to meet actual demand.
For enterprise decision-makers, the value of these cases is not that every organization should expect the same results.
It is that they provide a framework for evaluating MRI AI against specific operational and financial objectives.
Five Questions Enterprise Leaders Should Ask Before Scaling MRI AI
1. Will it work across our existing MRI fleet?
Evaluate compatibility with different manufacturers, field strengths, scanner generations, and existing OEM deep-learning technologies. A solution that performs well on one scanner may not meet the needs of a heterogeneous enterprise environment.
2. How will we validate clinical performance?
Establish a radiologist-led evaluation process with clear image-quality criteria, representative protocols, challenging clinical cases, and documented acceptance requirements.
3. How much usable capacity will faster scanning actually create?
Measure total examination time, not simply acquisition time. Patient preparation, positioning, room turnover, staffing, scheduling practices, and patient demand all influence whether shorter protocols translate into additional completed examinations.
4. Can IT support the solution across the network?
Assess MRI and PACS integration, cybersecurity, patient-data handling, centralized management, system availability, business continuity, and ongoing technical support. Enterprise scalability depends as much on operational architecture as it does on algorithm performance.
5. What is the financial impact compared with other investment options?
Compare the total cost of implementing MRI AI with manufacturer upgrades, additional scanner purchases, and alternative capacity investments. Include realistic assumptions about patient volume, utilization, implementation costs, and potential revenue.
These questions should be answered before an enterprise commits to network-wide deployment—not after the technology has been purchased.
For organizations developing an evaluation framework, AIRS Medical’s Enterprise MRI AI Buyer’s Guide and Toolkit provides additional resources for assessing clinical, technical, and financial requirements.
From Successful Pilots to Enterprise-Wide Value
The real measure of MRI AI isn’t how impressive an algorithm looks during a demonstration. It’s whether the technology can deliver meaningful improvements within the operational realities of a healthcare organization.
SimonMed demonstrated the ability to deploy across a large, diverse MRI fleet in a short period. MedStar Health showed how structured clinical evaluation and enterprise IT planning can support adoption. Invision Sally Jobe demonstrated how improving existing scanner performance can increase throughput while avoiding major capital expenditure.
Together, these cases show why enterprise MRI AI should be evaluated as more than an image-enhancement tool.
For healthcare executives, it can form part of a broader strategy to improve MRI utilization, manage capital investments, and increase imaging capacity using infrastructure already in place.
The question is no longer just how much faster an MRI scan can be. It’s how much more value an imaging organization can generate from the scanners it already owns.
Could Your Existing MRI Fleet Deliver More?
Explore how AIRS Medical’s SwiftMR can help your organization improve MRI capacity, standardize imaging performance, and maximize existing equipment investments.
Explore the AIRS Medical case studies
The results described are based on individual customer experiences and evaluations. Scan-time reductions, patient throughput, deployment requirements, and financial outcomes vary by MRI system, protocol, operational environment, and organization. Reported outcomes should not be interpreted as guaranteed results.